SI-BONE, Inc. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD from Q4 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
SI-BONE, Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q4 2017 to Q2 2024.
  • SI-BONE, Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending June 30, 2024 was $24.8M, a 21.4% increase year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $24.8M +$4.37M +21.4% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $22.1M -$491K -2.17% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $22M +$1.28M +6.19% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 $20M +$3.54M +21.5% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $20.4M +$5.3M +35.1% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $22.6M +$9.92M +78.2% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $20.7M +$6.43M +45.1% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $16.5M +$3.84M +30.4% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $15.1M +$3.22M +27.1% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $12.7M -$406K -3.1% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $14.2M +$635K +4.67% Dec 31, 2021 10-K 2023-03-02
Q3 2021 $12.6M +$1.2M +10.5% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $11.9M +$1.63M +15.9% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $13.1M +$3.73M +39.8% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $13.6M +$1.89M +16.1% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $11.4M +$1.5M +15.1% Sep 30, 2020 10-Q 2020-11-03
Q2 2020 $10.3M +$856K +9.1% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $9.36M +$950K +11.3% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 $11.7M +$3.23M +38.1% Dec 31, 2019 10-K 2021-03-10
Q3 2019 $9.92M +$2.83M +39.8% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $9.4M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $8.41M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $8.49M +$1.07M +14.4% Dec 31, 2018 10-K 2020-03-11
Q3 2018 $7.09M Sep 30, 2018 10-Q 2018-11-29
Q4 2017 $7.42M Dec 31, 2017 10-K 2019-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.